1. Home
  2. MDXH vs OPNW Comparison

MDXH vs OPNW Comparison

Compare MDXH & OPNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.21

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

OPNW

OpenWorld Inc. Common Stock

N/A

Current Price

$2.63

Market Cap

74.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MDXH
OPNW
Founded
2003
2023
Country
Belgium
Cayman Islands
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
74.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
MDXH
OPNW
Price
$0.21
$2.63
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $1.80
N/A
AVG Volume (30 Days)
★ 220.4K
57.5K
Earning Date
11-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $16,398,000.00
Revenue This Year
$5.10
N/A
Revenue Next Year
$13.22
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.40
$2.68
52 Week High
$5.33
$6.69

Technical Indicators

Market Signals
Indicator
MDXH
OPNW
Relative Strength Index (RSI) 20.10 20.22
Support Level N/A N/A
Resistance Level $0.64 $6.69
Average True Range (ATR) 0.06 0.69
MACD -0.02 -0.32
Stochastic Oscillator 0.47 1.70

Price Performance

Historical Comparison
MDXH
OPNW

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: